Chemistry:Bromperidol
From HandWiki
Short description: Chemical compound
| Clinical data | |
|---|---|
| Trade names | Bromidol, Bromodol, Erodium, Impromen, Tesoprel |
| Other names | Agostine; Azurene; Consilinon; C-C 2489; R-11333 |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C21H23BrFNO2 |
| Molar mass | 420.322 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Bromperidol, sold under the brand names Bromidol and Impromen among others, is a typical antipsychotic of the butyrophenone group which is used in the treatment of schizophrenia.[1][2] It was discovered at Janssen Pharmaceutica in 1966. An ester prodrug, bromperidol decanoate, is a long-acting form of bromperidol used as a depot injectable.[2]
References
- ↑ J. Elks, ed (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 182–. ISBN 978-1-4757-2085-3. OCLC 1058412474. https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA182.
- ↑ 2.0 2.1 Swiss Pharmaceutical Society (2000). Swiss Pharmaceutical Society. ed. Index Nominum 2000: International Drug Directory. Taylor & Francis. pp. 138–. ISBN 978-3-88763-075-1. https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA138.
Further reading
- "Clinical study with bromperidol, a new butyrophenone derivative". International Pharmacopsychiatry 12 (1): 20–4. 1977. doi:10.1159/000468282. PMID 873716.
- "Bromperidol, a new butyrophenone neuroleptic: a review". Psychopharmacology 78 (1): 1–7. 1982. doi:10.1007/BF00470578. PMID 6128755.

